| Model Number |
1L77-25 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
04/02/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided by the customer.
|
| |
|
Event or Problem Description
|
|
The customer reported falsely elevated architect tacrolimus results for one patient.Results provided: initial = 44ng/ml, repeat = 16ng/ml.There was no impact to patient management reported.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of tickets for lot 10002m800 did not identify an increase in complaint activity or trends related to the falsely elevated results.Return testing was not completed as returns were not available.Accuracy testing was performed with a retained kit of lot 10002m800 and a tacrolimus panel.All acceptance criteria were met, which indicates the product is performing acceptably.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect tacrolimus reagent, lot 10002m800.
|
| |
|
Search Alerts/Recalls
|